HopeStage
Back to all studies
RecruitingNCT02640911

Long-term use of antipsychotic medicines in schizophrenia

About this titleRead the official source — NCT02640911
Observational studyAges 18+China
The study in practice

Understand this study

Who could participate?

This study is for people with schizophrenia. Listed age limits: from 18 years. Other eligibility criteria apply.

Listed locations
ShanghaiSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateNovember 2010
Recruitment status
Recruiting
Enrollment listed in the registry
3,000
Sponsor
Shanghai Mental Health Center
Sponsor type
Hospital / academic medical center
Study type
Observational
Intervention type
Interview / survey / observational
Study phase
Not clearly listed
Locations
China
Age range
Over 18 Years
Official registry ID
NCT02640911
Official title
Show the full official title

An Observational Study on Atypical Antipsychotics Long-term Treatment Patients With Schizophrenia

Recruitment & locations

Currently recruiting

Shanghai

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Shanghai Mental Health Center, a hospital or academic medical center.

Who can participate?

This study is for people with schizophrenia. Listed age limits: from 18 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies